Mydecine Innovations Group Inc. announced the appointment of Todd Heinzl to its board of directors to replace Independent Director, Gordon Neal. Mr. Heinzl holds over 30 years of experience in the investment, merchant banking, and financial services industry. Mr. Heinzl's expertise centers around assisting globally minded small and mid-cap companies by developing adequate corporate governance policies.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.013 USD | +5.69% |
|
+15.04% | -12.75% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-12.75% | 803K | |
+22.15% | 46.56B | |
+45.15% | 41.67B | |
-2.37% | 41.16B | |
+33.84% | 32.4B | |
+20.42% | 28.18B | |
-6.35% | 28.1B | |
+48.83% | 14.52B | |
+45.00% | 13.74B | |
+0.06% | 12.17B |
- Stock Market
- Equities
- MYCOF Stock
- News Mydecine Innovations Group Inc.
- Mydecine Innovations Group Inc. Announces Board Changes